Introduction
Cornelia de Lange syndrome (CdLS) is a multiple congenital anomaly syndrome that is also known by the name of ''Brachmann-de Lange'' referring to the doctors who first described the syndrome. 1, 2 The estimated prevalence ranges from 1:45,000 to 1:62,000 as recently observed by a European working group. CdLS is characterized by a broad spectrum of distinctive clinical features: facial dysmorphisms (such as arched eyebrows, broad nasal bridge, thin upper lip and micrognatia), microcephaly, upper limb defects, psychomotor development delay, hirsutism, small stature, mental retardation and behavioural disorders (Fig. 1) . Cardiac, gastrointestinal, musculoskeletal, optical, uditive and neurosensory systems are often involved to varying degrees. Clinical involvement ranges from mild to severe (classic) phenotype. In about 50% of patients three different dominant gene mutations are detected: NIBPL (5p13), SMC1A (Xp11.22-p11.21) and SMC3 (10q25). Initial diagnosis is usually based on clinical features following specific diagnostic scoring systems 4 and can be confirmed by positive molecular genetic testing. Many studies focused on the importance of neurologic findings and reported an incidence of epilepsy in CdLS ranging from 14% to 25%, especially in the classic and more severe form of the syndrome. [4] [5] [6] [7] [8] [9] However, there is little information about seizure semiology, EEG findings and the natural course of epilepsy in CdLS patients reported in literature and data are not homogeneous. Therefore, the purpose of this multicenter study was to analyze the electroclinical aspects and the long term prognosis of patients with epilepsy.
Methods
A cohort of epileptic patients with CdLS was selected in nine neurological paediatric centres. The diagnosis of CdLS was made following the clinical diagnostic criteria developed by the consensus among the Clinical Advisory Board of the CdLS Foundation USA and the scientific advisory committee of the World CdLS Federation. 4 These criteria were focused on facial aspects, together with growth, developmental and behavioural deficits, correlated with findings reported in other major system, such as musculoskeletal, neurosensory, cutaneous and other major systems findings.
All patients were from non-consanguineous Caucasian parents. Age at onset, seizure semiology, EEG features, antiepileptic drug (AED) efficacy and neuroimaging studies were evaluated. All patients were followed for at least 5 years.
3. Results (see Table 1 )
Fourteen patients (female/male ratio = 11/3) with CdLS who developed seizures were evaluated. The mean age at seizure onset was 4.4 AE 3.6 years, and the mean age at the most recent follow-up was 12.6 AE 5.0 years. Out of fourteen patients, eleven (78.6%) suffered from focal seizures, sometimes evolving to generalized convulsions, while three patients (21.4%) had primary generalized tonic-clonic seizures. Two patients (14.6%) had a positive family history of febrile seizures or epilepsy; in addition, febrile seizures were reported in other two patients (14.6%). Interictal EEGs detected in ten cases (71.4%) focal anomalies: details of interictal abnormalities are reported in Table 1 . Cerebral magnetic resonance imaging (MRI) evidenced pathological findings in three subjects (21.4%). Valproate (VPA) monotherapy was undertaken in eight patients (57.1%), controlling seizure in seven; in one case VPA was administered in combination with topiramate (TPM), resulting in effective seizure control. One child who was unresponsive to VPA remained seizure-free after TPM therapy. Monotherapy with levetiracetam, carbamazepine or oxcarbazepine lead to remission in At the last follow-up, thirteen patients were seizure-free: one of these still had an abnormal EEG pattern. Only one child had both an abnormal EEG and a negative clinical outcome at the most recent evaluation.
Discussion
This study highlights for the first time a predominant seizure type and EEG pattern in epileptic patients with CdLS. The majority of our patients suffered from focal seizures, while the remaining patients showed generalized seizures or secondary generalizations. Interictal EEG recordings showed a prevalence of focal discharges, mainly localized in parieto-occipital region (Fig. 2) .
Although previous studies have reported an increased incidence of seizures in CdLS, a specific electroclinical pattern was not evidenced. Barr et al. 6 analyzed neurologic, genetic, EEG, and psychometric data in nineteen cases of CdLS and reported four severely mentally retarded patients who also had seizure and two with a questionable seizure history. A family history of seizures was reported in four patients: of which only two actually presented seizures. EEG findings were negative in these patients but other four asymptomatic patients showed bisynchronous and generalized epileptiform activity on EEG while one patient had focal right temporal epileptiform activity. As we experienced, photic stimulation did not activate anomalies in any of the nineteen patients, whereas three patients with epileptiform activity had additional sleep-activated multifocal spike discharges. Hawley et al. 7 described an interesting link between classic phenotype, lower birth weight and seizure incidence after assessing sixty-four patients with CdLS. Selicorni et al. 11 detected seizures in six out of thirty patients with CdLS, five with classic type and one with mild type. Deardorff et al. 8 noted an incidence of non-specified seizure in CdLS of about 25%. Kline et al. 10 evaluating forty-nine patients affected by CdLS, described an incidence of seizure of 26%, with a typical age of onset prior to 18 years and well-controlled with AED monotherapy. In another study Kline et al. included seizures in primary neurologic involvements of the syndrome, with an incidence of 23% but without describing their EEG pattern; they included seizures in main diagnostic criteria. The main limitation of this study is the small sample number, which did not allow a more detailed comparison between endophenotypes.
This is the first study that describes the long term follow-up of CdLS patients with epilepsy. Our data highlight a favourable prognosis of epilepsy, reporting a tendency to a rapid and excellent long-term response to AED therapy, despite one case of spontaneous remission. In addition, the recurrence rate after discontinuation was low: one patient out of fourteen (7,1%) suffered recurrent seizures. Overall, AED common approach, and especially VPA monotherapy, seems effective in controlling seizures of patients with CdLS. Moreover, our experience suggests that frequently AED therapy can be withdrawn after few years of seizure-free follow-up. Although we did not observe any correlation between MRI, seizures and EEG abnormalities, a remarkable correlation between EEG features and clinical expressions was found: seizure remission was followed by EEG normalization in most of the cases. The predominant clinical EEG aspects of our sample could fill the criteria of benign occipital epilepsy, even though the number of our patients is small. Recently 12 it has been proposed the hypothesis of the existence of the so-called System Epilepsies. The hypothesis claims that System Epilepsies are the result of the enduring propensity to generate seizures of different brain areas that, alone, are unable to create a specific electroclinical phenotype and go beyond the dichotomy between focal and generalized epilepsy. If neurophysiologic studies in CdLS patients add precise information about the structures and functions of the neural network involved in epilepsy of these patients, it could be confirmed that this epilepsy can be included in the possible prototypes of System Epilepsy.
Conclusions
In conclusion, our clinical series suggests that partial seizures and focal anomalies mainly on parieto-occipital areas are common features in CdLS patients with epilepsy. Electroclinical outcome of this type of epilepsy is generally favourable, with a good response to monotherapy.
